Landcent is a global, science-driven healthcare company dedicated to accelerating the fight against diseases of poverty, starting with malaria. Headquartered in the Netherlands, with operations in Ghana and China, Landcent recognizes that malaria remains one of the world’s most devastating and inequitable health challenges, disproportionately affecting the most vulnerable communities. Despite decades of progress, malaria cases continue to rise, with 1,645 deaths occurring every day—95 percent in sub-Saharan Africa and 75 percent among children under five—driven by growing insecticide resistance and limited product innovation. Landcent exists to change this trajectory.

Landcent identifies critical gaps across the prevention, diagnosis, and treatment landscape, and develops and delivers impactful solutions to address them. As a company, Landcent is approaching a pivotal moment with the upcoming market launch of several impactful products, including the flagship bed net, several essential diagnostics, and a malaria medicine. By 2030, Landcent’s products are expected to protect more than 46 million people from malaria.